Diverse perspectives on science and medicine
Ginny Barbour, Medicine Editorial Director at PLOS, discusses a recently-published UK Government spending report on access to clinical trial information and the stockpiling of Tamiflu. Yesterday the UK Parliament’s Public Accounts Committee, which monitors UK
Reshma Ramachandran and David Carroll warn that the Trans-Pacific Partnership will trample over access to affordable medicines Last month, Wikileaks posted the complete Intellectual Property (IP) Chapter of the secretly-negotiated Trans-Pacific Partnership Agreement (TPP) confirming
This week PLOS Medicine publishes the following new articles: The Maternal Health Task Force (MHTF) and PLOS Medicine issue the call for papers for Year 3 of the MHTF-PLOS Collection: Integrating Health Care to Meet
This week PLOS Medicine publishes the following new articles: The Maternal Health Task Force (MHTF) and PLOS Medicine issue the call for papers for Year 3 of the MHTF-PLOS Collection: Integrating Health Care to Meet
This week PLOS Medicine publishes the following articles: “Evergreening” strategies, where pharmaceutical companies slightly change the formulation of their brand drug into “follow on” drugs by combining formulations or producing slow-release forms, can extend drug
Suerie Moon and John-Arne Røttingen from Harvard University call for WHO member states to embrace new approaches to governing the global research and development system. This week at the World Health Assembly in Geneva, WHO
Kristine Husøy Onarheim and Johanne Helene Iversen from Universities Allied for Essential Medicines write about the broken system for drug development, and how governments are given an opportunity to address it. The member states of
Síle Lane from Sense About Science discusses the recent European Court injunction on clinical trial data. The European General Court has issued an injunction to prevent the European medicines regulator from releasing information from clinical
Kate Elder and Jennifer Cohn from Médecins Sans Frontières question why new vaccines are so expensive. Global health leaders will gather in Abu Dhabi on April 24-25 for a Vaccine Summit to discuss recent accomplishments
In this gloomy northern hemispheric spring, it seems there is something interesting and encouraging going on in public health. Finally, perhaps the status quo in what is acceptable to inform clinical medicine is now changing,
